Compare Bristol-Myers Squibb Co (BMY) vs Mongodb Inc (MDB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Mongodb Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.7 (market cap $129.94B), while Mongodb Inc trades at $433.03 (market cap $35.32B). The key difference: Bristol-Myers Squibb Co is far larger — about 3.7× Mongodb Inc's market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while Mongodb Inc pays none. Which is the better fit depends on your goals.
| BMY | MDB | |
|---|---|---|
Market Cap | $129.94B | $35.32B |
Sector | Health | Technology |
52-Week High | $65.89 | $440.25 |
52-Week Low | $42.60 | $204.37 |
Enterprise Value | $163.92B | $32.93B |
Dividend Yield | 3.96% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Mongodb Inc
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →
